Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 46 of 46 publications.

Rothman KJ. The public-health mindset : review of "The public health approach - population thinking from the black death to COVID-19" by Alfredo Morabia, Johns Hopkins University Press, 2023. Eur J Epidemiol. 2024 Mar;39(3):323-4. doi: 10.1007/s10654-024-01108-6

Smith LH, Garcia-Albeniz X, Chan JM, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR, Hernan MA. Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula. Eur J Epidemiol. 2022 Dec 1;37(12):1205-13. doi: 10.1007/s10654-022-00929-7

Garcia-Albeniz X, Del Amo J, Polo R, Morales-Asencio JM, Hernan MA. Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19. Eur J Epidemiol. 2022 Aug 9;37(8):789-96. doi: 10.1007/s10654-022-00891-4

Alemany S, Avella-Garcia C, Liew Z, Garcia Esteban R, Inoue K, Cadman T, Lopez-Vicente M, Gonzalez L, Riano Galan I, Andiarena A, Casas M, Margetaki K, Strandberg-Larsen K, Lawlor DA, EL Marroun H, Tiemeier H, Iniguez C, Tardon A, Santa-Marina L, Julvez J, Porta D, Chatzi L, Sunyer J. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: meta-analysis in six European population-based cohorts. Eur J Epidemiol. 2021 Oct;36(10):993-1004. doi: 10.1007/s10654-021-00754-4

Rothman KJ. The origin of Modern Epidemiology, the book. Eur J Epidemiol. 2021 Aug;36(8):763-5. doi: 10.1007/s10654-021-00790-0

Chen ZX, Hohmann L, Banjara B, Zhao Y, Diggs K, Westrick SC. Recommendations to protect patients and health care practices from Medicare and Medicaid fraud. J Am Pharm Assoc. 2020 Nov;60(6):e60-5. doi: 10.1016/j.japh.2020.05.011

Ilomaki J, Bell JS, Chan EW, Tolppanen A-M, Luo H, Wei L, Lai EC, Shin J-U, De Paoli G, Pajouheshnia R, Ho FK, Reynolds L, Lau KK, Crystal S, Lau WCY, Man KKC, Brauer R, Chan AYL, Shen C-Y, Kim JH, Lum TYS, Hartikainen S, Koponen M, Rooke E, Bazelier M, Klungel O, Setoguchi S, Pell JP, Cook S, Wong ICK. Application of healthcare 'big data' in CNS drug research: the example of the neurological and mental health global epidemiology network (NeuroGEN). CNS Drugs. 2020 Sep;34(9):897-913. doi: 10.1007/s40263-020-00742-4

Gignac F, Romaguera D, Fernandez-Barres S, Phillipat C, Garcia-Esteban R, Lopez-Vicente M, Vioque J, Fernandez-Somoano A, Tardon A, Iniguez C, Lopez-Espinosa MJ, Garcia de la Hera M, Amiano P, Ibarluzea J, Guxens M, Sunyer J, Julvez J. Maternal nut intake in pregnancy and child neuropsychological development up to 8 years old: a population-based cohort study in Spain. Eur J Epidemiol. 2019 May;34(7):661-73. doi: 10.1007/s10654-019-00521-6

Pladevall-Vila M, Pottegard A, Schink T, Reutfors J, Morros R, Poblador-Plou B, Timmer A, Forns J, Hellfritzsch M, Reinders T, Hagg D, Giner-Soriano M, Prados-Torres A, Cainzos-Achirica M, Hallas J, Brandt L, Cortes J, Aguado J, Perlemuter G, Falissard B, Castellsague J, Jacquot E, Deltour N, Perez-Gutthann S. Risk of acute liver injury in agomelatine and other antidepressant users in four European countries: a cohort and nested case-control study using automated health data sources. CNS Drugs. 2019 Apr;33(4):383-95. doi: 10.1007/s40263-019-00611-9

Vinceti M, Filippini T, Rothman KJ. Selenium exposure and the risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Epidemiol. 2018 Sep;33(0):789-810. doi: 10.1007/s10654-018-0422-8.

Nagar SP, Rane PP, Fox KM, Meyers J, Davis K, Beaubrun A, Inomata H, Qian Y, Kajinami K. Treatment patterns, statin intolerance, and subsequent cardiovascular events among Japanese patients with high cardiovascular risk initiating statin therapy. Circ J. 2018 Mar 23;82(4):1008-16. doi: 10.1253/circj.CJ-17-0811

Rothman KJ. The growing rift between epidemiologists and their data. Eur J Epidemiol. 2017 Oct;32(10):863-5. doi: 10.1007/s10654-017-0314-3

Garcia-Albeniz X, Hsu J, Hernan MA. The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening. Eur J Epidemiol. 2017 Jun;32(6):495-500. doi: 10.1007/s10654-017-0287-2

Heritier H, Vienneau D, Foraster M, Eze IC, Schaffner E, Thiesse L, Rudzik F, Habermacher M, Kopfli M, Pieren R, Brink M, Cajochen C, Wunderli JM, Probst-Hensch N, Roosli M. Transportation noise exposure and cardiovascular mortality: a nationwide cohort study from Switzerland. Eur J Epidemiol. 2017 Apr;32(4):307-15. doi: 10.1007/s10654-017-0234-2

Rothman KJ. Disengaging from statistical significance - Commentary. Eur J Epidemiol. 2016 May;31(5):443-4. doi: 10.1007/s10654-016-0158-2

Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016 Apr;31(4):337-50. doi: 10.1007/s10654-016-0149-3

Brodtkorb TH, Bell M, Irving AH, Laramee P. The cost effectiveness of nalmefene for reduction of alcohol consumption in alcohol-dependent patients with high or very high drinking-risk levels from a UK societal perspective. CNS Drugs. 2016 Feb;30(2):163-77. doi: 10.1007/s40263-016-0310-2

Garcia-Albeniz X, Hsu J, Lipsitch M, Logan RW, Hernandez-Díaz S, Hernan MA. Infective endocarditis and cancer in the elderly. Eur J Epidemiol. 2016 Jan;31(1):41-9. doi: 10.1007/s10654-015-0111-9

Hatch EE, Hahn KA, Mikkelsen EM, Riis EH, Sorensen HT, Rothman KJ, Wise LA. Pre-gravid oral contraceptive use in relation to birth weight: a prospective cohort study. Eur J Epidemiol. 2015 Nov;30(11):1199-208.

Vickers AD, Mody R, Bergman A, Ling CS, Ainsworth C, Medjedovic J, Smyth M. Comparative efficacy of biologics in the treatment of moderately to severely active ulcerative colitis (UC): a systematic review and network meta-analysis. Poster presented at the 2015 Digestive Disease Week; May 2015. Washington, DC. [abstract] Gastroenterology. 2015 Apr 16; 148(4, Suppl 1):S272. Previously presented at the 10th Congress of the European Crohn's and Colitis Organization.

Nussbaumer B, Morgan LC, Reichenpfader U, Greenblatt A, Hansen RA, Van Noord M, Lux L, Gaynes BN, Gartlehner G. Efficacy and risk of harms of immediate-versus extended-release second-generation antidepressants: a systematic review with network meta-analysis. CNS Drugs. 2014 Aug;28(8):699-712. doi: 10.1007/s40263-014-0169-z

Vinceti M, Malagoli C, Rothman KJ, Rodolfi R, Astolfi G, Calzolari E, Puccini A, Bertolotti M, Lunt M, Paterlini L, Martini M, Nicolini F. Risk of birth defects associated with maternal pregestational diabetes. Eur J Epidemiol. 2014 Jun;29(6):411-8.

Odom DM, Mladsi DM, Saag K, Ronquest NA, Wang J. Estimating the relationship between diclofenac drug dosage and risk of gastrointestinal toxicity: meta-regression based on a systematic literature review. Poster presented at the 2013 Digestive Disease Week; May 2013. Orlando, FL. [abstract] Gastroenterology. 2013 May; 144(5 Suppl 1):S-673. doi: 10.1016/S0016-5085(13)62496-8

Vinceti M, Rothman KJ, Crespi CM, Sterni A, Cherubini A, Guerra L, Maffeis G, Ferretti E, Fabbi S, Teggi S, Consonni D, De Girolamo G, Meggiato A, Palazzi G, Paolucci P, Malagoli C. Leukemia risk in children exposed to benzene and PM10 from vehicular traffic: a case–control study in an Italian population. Eur J Epidemiol. 2012 Oct 1;27(10):781-90.

Phipps AI, Newcomb PA, Garcia-Albeniz X, Hutter CM, White E, Fuchs CS, Hazra A, Ogino S, Nan H, Ma J, Campbell PT, Figueiredo JC, Peters U, Chan AT. Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer. Gastroenterology. 2012 Jul;143(1):51-4. doi: 10.1053/j.gastro.2012.04.052

Rothman KJ, Stein Z, Susser M. Rebuilding bridges: what is the real role of social class in disease occurrence? Eur J Epidemiol. 2011 Jun;26(6):431-2.

Carroll IM, Ringel-Kulka T, keku TP, Chang Y-H, Packey CD, Neil SK, Williamson D, Sartor RB, Ringel Y. Molecular characterization of the fecal and colonic mucosal-associated microbiota in diarrhea-predominant irritable bowel syndrome patients. Poster presented at the Digestive Disease Week; May 7, 2011. Chicago, IL. [abstract] Gastroenterology. 2011 May; 140(5, Suppl 1):S373. doi: 10.1016/S0016-5085(11)61523-0

Chung RT, Bisceglie A, Poordad FF, Hassanein T, Zhou X, Lentz E, Prabhakar A, Hamzeh FM. Association of host pharmacodynamic effects and virologic response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis c. Poster presented at the 2010 Digestive Disease Week; May 1, 2010. New Orleans, LA. [abstract] Gastroenterology. 2010 May; 138(5_suppl_1):S-841.

Huybrechts KF, Mikkelsen EM, Christensen T, Riis AH, Hatch EE, Wise LA, Sorensen HT, Rothman KJ. A successful implementation of e-epidemiology: the Danish pregnancy planning study 'Snart-Gravid'. Eur J Epidemiol. 2010 May 1;25(5):297-304.

Rothman KJ. Curbing type I and type II errors. Eur J Epidemiol. 2010 Apr 1;25(4):223-4.

Schwab PE. Tobacco survey results/ cigarette sales in pharmacy: consumer research and analysis to support merchandising decisions. Poster presented at the 2010 American College of Apothecaries Mid-Year Meeting; March 2010. Memphis, TN. [abstract] J Am Pharm Assoc. 2010 Mar; 50(2).

Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome foundation report. Gastroenterology. 2009 Dec 1;137(6):1944-53.

Mehta S, Nagar SP, Aparasu R. Unmet prescription medication need in U.S. children. J Am Pharm Assoc. 2009 Nov;49(6):769-76.

Lundbye-Christensen S, Dethlefsen C, Gorst-Rasmussen A, Fischer T, Schønheyder HC, Rothman KJ, Sørensen HT. Examining secular trends and seasonality in count data using dynamic generalized linear modeling: a new methodological approach illustrated with hospital discharge data on myocardial infarction. Eur J Epidemiol. 2009;24(5):225-30.

Johnson FR, Ozdemir F, Mansfield CA, Hass S, Miller DP, Siegel CA, Sands BE. Crohn's disease patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy. Gastroenterology. 2007 Sep;133(3):769-79.

Skriver MV, Pedersen L, Stang P, Lund L, Rothman KJ, Sorensen HT. The month of birth does not affect the risk of hypospadias. Eur J Epidemiol. 2004 Dec 1;19(12):1135-6.

Rothman KJ, Mahon BE. Confounding and effect-measure modification in the evaluation of immunogenic agents. Eur J Epidemiol. 2004 Mar;19(3):205-7.

Andrews EB, Gilsenan A, Cook SF. Therapeutic Risk Management Interventions: feasibility and Effectiveness. J Am Pharm Assoc. 2004 Jan 1;44(4):491-500.

Watson ME, Lacey LA, McSorley DJ, Kong NS, Northcutt AR, Mangel AW. Patient satisfaction with alosetron for the treatment of irritable bowel syndrome (IBS). Poster presented at the Digestive Disease Week and the 101st Annual Meeting of the American Gastroenterological Association; May 2000. [abstract] Gastroenterology. 2000 Apr; 118((4) Part 1):A219.

Northcutt AR, Camilleri M, Mayer EA, Dossman DA, Dukes GE, Ehsanullah RSB, McSorley DJ. Alosetron, a 5-HT3-receptor antagonist, is effective in the treatment of female irritable bowel syndrome patients. Gastroenterology. 1998;114:A812.

Carlson AM, Stockwell-Morris L, Perfetto EM, Appel AM, Gilsenan AW. Quality of sleep in patients with osteoarthritis treated with extended-release and conventional etodolac. J Am Pharm Assoc. 1998 Jan;38(1):31-6. doi: 10.1016/S1086-5802(16)30297-2

Vakil N, McSorley DJ. The incremental cost and utility of cultures for helicobacter pylori. Gastroenterology. 1997;112(4):A319.

Perschy TB, McSorley DJ. Ranitidine bismuth citrate in combination with clarithromycin is effective against h. pylori strains with susceptible or intermediate clarithromycin sensitivity. Gastroenterology. 1997;112(4):A257.

Peterson WL, Sontag SJ, Ciociola AA, Sykes DL, McSorley DJ, Webb DD, the H. pylori Ulcer Group. Ranitidine bismuth citrate plus clarithromycin is effective in the eradication of helicobacter pylori and prevention of duodenal ulcer relapse. Poster presented at the Digestive Disease Week and the 95th Annual Meeting of the American Gastroenterological Association; May 1995. [abstract] Gastroenterology. 1995 Apr; 108(4 (Suppl 1)):A190. doi: 10.1016/0016-5085(95)23422-5

Ciociola AA, Koch KM, McSorley DJ. Safety and pharmacokinetics of chronic oral dosing of gr122311x (ranitidine bismuth citrate), a new bismuth compound with anti-secretory activity. Gastroenterology. 1992;102(4):A50.

Ciociola AA, Koch KM, McSorley DJ. Safety and pharmacokinetics of ascending oral doses of gr122311x (ranitidine bismuth citrate), a new bismuth compound with anti-secretory properties. Gastroenterology. 1992;102(4):A51.